Austria

mySugr wants to improve diabetes patient experience with apps

mySugr Importer (English) from mySugr on Vimeo. mySugr is a diabetes app developer that’s striving to set itself apart from other direct-to-consumer mobile health companies for chronic conditions. Its apps are intended to strike a balance between relevant and important information for its users with colorful graphics and a gaming component. With a $4.8 million […]

Nabriva Therapeutics raises $120M for drugs that attack antibiotic resistant bacteria that cause pneumonia

Transatlantic antibiotics maker Nabriva Therapeutics just raised an enormous swath of cash – it just closed a $120 million Series B round to treat serious and highly resistant bacterial infections. It’s validation for a largely underused class of antibiotics – pleuromutilins – and a step in the direction to address global antibiotic resistance. The first, $50 million tranche […]